Clinical trial
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
NCT00030771 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00030771 |
|---|---|
| Title | Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients |
| Official title | Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Chemotherapy, Radiotherapy, Surgery |
| Enrollment | 232 |
| Start date | Apr 4, 2001 |
| Primary completion | Apr 9, 2014 |
| Completion | Sep 15, 2023 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 17, 2024 |
| Countries | Germany, Serbia, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: